Brief: Lunglife Ai Now Expects Clinical Validation Study To Be Concluded In Q4 2023
28/09/2023 08:32
Sept 28 (Reuters) - LungLife AI Inc LLAI.L :
* LUNGLIFE AI, INC - CLINICAL VALIDATION STUDY UPDATE
* LUNGLIFE AI INC - DUE TO DELAYS IN PROVISION OF DATA FROM
STUDY
SITES, WE NOW EXPECT THIS TO BE CONCLUDED IN Q4 2023
Source text for Eikon: ID:nRSb9096Na
Further company coverage: LLAI.L
((Reuters.Briefs@thomsonreuters.com;))